title: Fludarabine, cyclophosphamide, and antithymocyte globulin for a patient with dyskeratosis congenita and severe bone marrow failure.
authors.forename: Fabiana
authors.initials: F
authors.lastname: Ostronoff
authors.forename: Mauricio
authors.initials: M
authors.lastname: Ostronoff
authors.forename: Rodolfo
authors.initials: R
authors.lastname: Calixto
authors.forename: Rodrigo
authors.initials: R
authors.lastname: Florêncio
authors.forename: Mariana C
authors.initials: MC
authors.lastname: Domingues
authors.forename: Ana Patricia
authors.initials: AP
authors.lastname: Souto Maior
authors.forename: Alexandre
authors.initials: A
authors.lastname: Sucupira
authors.forename: Clemente
authors.initials: C
authors.lastname: Tagliari
mesh_terms: D000961:Antilymphocyte Serum / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001855:Bone Marrow Diseases / Q000150:complications / Q000188:drug therapy; D002675:Child, Preschool; D003520:Cyclophosphamide / Q000627:therapeutic use; D019871:Dyskeratosis Congenita / Q000150:complications / Q000188:drug therapy*; D005260:Female; D006801:Humans; D014740:Vidarabine / Q000031:analogs & derivatives / Q000627:therapeutic use
chemical_list: D000961:Antilymphocyte Serum; D003520:Cyclophosphamide; D014740:Vidarabine; C024352:fludarabine